Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet Therapy (Tirofiban, Prasugrel) for SVG Patency
NCT01598337Phase 3Unknown
- Sponsor
- Prince Sultan Cardiac Center
- Start
- Apr 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tirofiban, prasugrel in coronary artery disease (CAD), sponsored by Prince Sultan Cardiac Center. Status: unknown.
02
Drugs
tirofibanprasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01598337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01598337.